Cumberland pharmaceuticals inc. (CPIX)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:
Revenues

47,533

40,741

41,150

33,025

-

-

-

-

-

-

-

Net product revenue

-

-

-

-

33,013

36,683

31,100

47,944

50,893

44,704

-

Other revenue

-

-

-

-

505

218

926

907

248

1,171

-

Net product revenue

-

-

-

-

-

-

-

-

-

-

43,142

Other revenue

-

-

-

-

-

-

-

-

-

-

394

Net revenues

-

-

-

-

33,519

36,901

32,027

48,851

51,142

45,876

43,537

Costs and expenses:
Cost of products sold

8,752

7,378

7,370

5,958

-

-

-

-

-

-

-

Cost of products sold

-

-

-

-

4,968

5,053

5,439

5,046

5,362

3,586

4,136

Selling and marketing

21,429

20,258

21,492

14,553

13,994

14,902

14,387

20,329

20,940

22,674

20,194

Research and development

6,478

7,575

4,280

3,190

3,847

3,389

5,615

5,095

5,028

4,327

4,993

General and administrative

10,362

10,150

9,651

8,561

7,607

8,401

9,489

9,055

9,307

8,099

7,643

Amortization

4,134

2,769

2,436

2,194

1,989

1,596

896

506

655

686

686

Other

-

-

-

-

-

-

-

-

-

-

106

Total costs and expenses

51,156

48,132

45,231

34,458

32,407

33,343

35,828

40,033

41,293

39,374

37,760

Operating income (loss)

-3,623

-7,390

-4,081

-1,433

1,111

3,558

-3,801

8,818

9,849

6,501

5,776

Interest income

243

564

299

204

209

251

230

304

210

200

79

Interest expense

246

195

92

106

73

67

103

71

353

1,423

772

Income (loss) from continuing operations before income taxes

-3,625

-7,022

-3,874

-1,334

1,246

3,743

-3,674

9,050

9,706

5,278

5,083

Income tax (expense) benefit

-79

16

4,174

-330

575

1,380

-1,523

3,244

4,080

2,851

2,024

Net income (loss)

-3,546

-7,038

-8,049

-1,003

671

2,362

-2,151

5,806

5,626

2,427

3,058

Net (income) loss at subsidiary attributable to noncontrolling interests

-8

-75

-71

-59

-60

-61

-46

-36

-31

-29

-32

Net income (loss) attributable to common shareholders

-3,537

-6,963

-7,978

-944

731

2,423

-2,104

5,842

5,657

2,456

3,091

Earnings (loss) per share attributable to common shareholders
Earnings (loss) per share attributable to common shareholders - basic (in dollars per share)

-0.23

-0.45

-0.50

-0.06

0.04

0.14

-0.11

0.30

0.28

0.12

0.22

Earnings (loss) per share attributable to common shareholders - diluted (in dollars per share)

-0.23

-0.45

-0.50

-0.06

0.04

0.14

-0.11

0.30

0.28

0.12

0.17

Weighted-average shares outstanding
- basic (in shares)

15,396

15,614

15,911

16,236

16,715

17,617

18,332

19,564

20,342

20,333

14,199

- diluted (in shares)

15,396

15,614

15,911

16,236

17,094

17,899

18,332

19,787

20,572

21,058

18,234

Comprehensive income (loss) attributable to common shareholders

-3,537

-6,963

-7,978

-944

731

2,423

-2,104

5,842

-

-

-

Net loss at subsidiary attributable to noncontrolling interests

-8

-75

-71

-59

-60

-61

-46

-36

-

-

-

Total comprehensive income (loss)

-3,546

-7,038

-8,049

-1,003

671

2,362

-2,151

5,806

5,626

2,427

-

Product
Revenues

45,552

40,200

40,376

32,478

-

-

-

-

-

-

-

Other
Revenues

1,981

540

773

547

-

-

-

-

-

-

-